Archive for July, 2009

FDA warns against body-building products claiming steroids

Body Building SupplementsThe Food and Drug Administration warned the public Tuesday not to use body-building products marketed as containing steroids or steroid-like substances. “Products marketed for body building and claiming to contain steroids or steroid-like substances are illegal and potentially quite dangerous,” said the agency’s commissioner, Dr. Margaret Hamburg.

Click here to read more…

Study uncovers potential Avandia liver failure risk

An analysis of adverse events reported to the Food and Drug Administration has uncovered 11 deaths due to liver toxicity among patients taking the diabetes drug Avandia. The consumers group Public Citizen, which conducted the analysis, estimates that because few side effects cases are reported to the FDA, the actual number of patients who developed liver failure after using Avandia could be much higher.

Click here to read more…

Young You Corporation Issues a Voluntary Nationwide Recall of Weight Loss Pills

Young You Corporation has been informed by the Food and Drug Administration (FDA) that four weight loss dietary supplements sold and marketed by the firm contain an undeclared drug ingredient. The FDA has not approved the following products as drugs; therefore the safety and effectiveness of this product is unknown.  All lots of the following dietary supplement products are being recalled: Slimbionic, One Weight Loss Pill 30 capsules, SlimDemand Capsules, and Botanical Weight Loss.

Click here to read more…

Brazil ordered to compensate thalidomide victims

A federal court has ordered the Brazilian government to compensate children of mothers who took thalidomide, a drug that caused birth defects in thousands of people across the world but was withdrawn tardily in Brazil. Thalidomide was introduced in Brazil in 1957 as an anesthetic against discomforts experienced during pregnancy, but as elsewhere it resulted in severe fetal congenital defects among users.

Click here to read more…

Manufacturer recalls drug central to Jackson death probe

The manufacturer of propofol has announced that it is recalling two lots of the anesthetic drug after they were linked to dozens of cases of bacterial contamination. Teva Pharmaceuticals was also recently contacted by federal officials investigating the death of Michael Jackson over concerns that the pop singer may have taken Diprivan—the brand-name version of propofol—before his death.

Click here to read more…

FDA scrutinizing safety of asthma drug Xolair

XolairThe Food and Drug Administration announced Thursday it is conducting a safety review of the asthma drug Xolair after data from an ongoing study suggested an increased number of heart attacks and strokes among patients who use it. The data “suggest a disproportionate increase in ischemic heart disease, arrhythmias … cardiac failure” and other conditions “in patients treated with Xolair compared to the control group of patients not given the drug,” the agency said.

Click here to read more…

Hormone Therapy Raises Ovarian Cancer Risk

Women who are on hormone therapy or who have used it in the recent past are at higher risk of ovarian cancer than women who have never been on hormone therapy, a new study shows. The increase in risk was found regardless of the hormone dose or formulation, whether hormones were taken by mouth, transdermal patch, or vaginally, or whether the treatment included just estrogen or estrogen and progestin, the researchers say.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.